期刊文献+

急性ST段抬高型心肌梗死患者经皮冠脉介入术后血清分泌型卷曲相关蛋白5水平与早期心功能恢复的关系 被引量:1

Relationship between Serum Secreted Frizzled Related Protein 5 Level and Early Cardiac Function Recovery after Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction Patients
原文传递
导出
摘要 目的探讨急性ST段抬高型心肌梗死(STEMI)患者经皮冠脉介入术(PCI)后血清分泌型卷曲相关蛋白5(SFRP5)对早期心功能的影响。方法选择2017年6月至2018年5月收治的首次出现STEMI且PCI治疗成功的患者104例作为STEMI组,另选取同期出现胸痛症状并疑似冠状动脉粥样硬化性心脏病,但没有明显的冠状动脉狭窄的患者50例作为对照组。比较两组患者心功能指标及血清SFRP5水平。采用单因素及多因素logistic回归分析STEMI患者左心室射血分数(LVEF)改善的影响因素。结果STEMI组患者血清SFRP5基线水平高于对照组(P<0.05)。STEMI组患者入院时、入院后24 h、72 h血清SFRP5水平逐渐降低(P<0.05),但均高于对照组(P<0.05)。根据STEMI组患者基线血清SFRP5水平中位值(26.8 ng/ml),将其分为低水平亚组(<26.8 ng/ml,n=51)和高水平亚组(≥26.8 ng/ml,n=53)。两个亚组STEMI患者入院时LVEF、左心室舒张末期容积(LVEDV)差异均无统计学意义(P>0.05),但是PCI术后3个月,高水平亚组STEMI患者LVEF高于低水平亚组,且差异均有统计学意义(P<0.05)。Spearman相关分析结果显示,STEMI患者入院时、入院后24 h血清SFRP5水平与PCI术后3个月LVEF呈正相关(r=0.353、0.263,P<0.05),但与PCI术后3个月LVEDV、峰值超敏心肌肌钙蛋白I及峰值超敏C反应蛋白无相关性(P>0.05)。经单因素和多因素logistic回归分析,入院时血清SFRP5水平是影响STEMI患者LVEF改善情况的独立相关因素(P<0.05)。结论高SFRP5水平对于促进STEMI患者PCI术后的心功能恢复有重要价值,是STEMI患者LVEF改善的独立预测因子。 Objective To investigate the effect of serum secreted frizzled related protein 5(SFRP5)on early cardiac function after percutaneous coronary intervention(PCI)in acute ST-segment elevation myocardial infarction(STEMI).Methods From June 2017 to May 2018,patients admitted to the emergency department of our hospital with STEMI for the first time and successfully treated with PCI were recruited as STEMI group(n=104),and patients with chest pain and suspected coronary heart disease but no significant coronary artery stenosis were selected as the control group(n=50).Univariate and multivariate logistic regression were used to analyze the factors influencing left ventricular ejection fraction(LVEF)improvement in STEMI patients.Results The serum SFRP5 level at baseline in STEMI group was higher than that in control group(P<0.05),and the serum SFRP5 level decreased with time(P<0.05),and the serum SFRP5 level at each time point in STEMI group was significantly higher than that in control group(P<0.05).STEMI patients were divided into low subgroup(<26.8 ng/ml,n=51)and high subgroup(≥26.8 ng/ml,n=53)according to the median baseline serum SFRP5 level(26.8 ng/ml).There were no statistically significant differences in LVEF and left ventricle end-diastolic volume(LVEDV)values between the two subgroups at T0(P>0.05),but after 3 months,LVEF values in the high subgroup were higher than those in the low subgroup(P<0.05).Spearman rank correlation coefficient analysis showed that serum SFRP5 level at T0 and T1 of STEMI patients were positively correlated with LVEF 3 months later(r=0.353,0.263,P<0.05).However,there was no significant correlation with LVEDV,peak value of high-sensitivity cardiac troponin I(hs-cTnI)and peak value of hypersensitive C-reactive protein(hs-CRP).Multivariate logistic regression analysis showed that serum SFRP5 level at T0 was an independent clinical factor of LVEF improvement in STEMI patients(P<0.05).Conclusion High SFRP5 level are of important value in promoting cardiac function recovery after PCI and is an independent predictor of LVEF improvement in STEMI patients.
作者 杜聪慧 边春云 郝雁 DU Cong-hui;BIAN Chun-yun;HAO Yan(Department of Emergency,The First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,Hebei,China;Department of Cardiology CCU,The First Affiliated Hospital of Hebei North University,Zhangjiakou 075000,Hebei,China)
出处 《中国分子心脏病学杂志》 CAS 2021年第6期4287-4291,共5页 Molecular Cardiology of China
基金 张家口市重点研发计划项目(2020107D)。
关键词 急性ST段抬高型心肌梗死 经皮冠脉介入术 分泌型卷曲相关蛋白5 心功能 左心室射血分数 Acute ST-segment elevation myocardial infarction Percutaneous coronary intervention Secreted frizzled related protein 5 Cardiac function Left ventricular ejection fraction
  • 相关文献

参考文献5

二级参考文献50

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2044
  • 3Hansson G K, Hermansson A. The immune system in athemscle- rosis [J]. Nat lmmuno1,2011,12 ( 3 ) :204 - 12.
  • 4Bouziana S,Tziomalos K, Goulas A. The role of adipokines in iseh- emicstroke risk stratification[J].lnt J Stroke,2016,11 ( 4 ) : 389 - 98.
  • 5Shibata R, Ohashi K, Mumhara T, et al. The potential of adipo* kines as therapeutic agents for cardiovascular disease [ J]. Cyto- kine Growth Factor Rev ,2014,25 (4) :483 - 7.
  • 6Alexopoulos N, Katritsis D, Raggi P. Visceral adipose tissue as a source of intlamma~ion and promoter of" atheroscierosis[J]. Athero- sclerosis,2014,233 (1) :104-12.
  • 7Park A C, Huang G, Jankowska-Gan E, et al. Mucosal adminis- tration of collagen V ameliorates the atherosclerotic plaque burden by inducing interleukin 35-dependent tolerance[J].J Biol Chem, 2016,291 (7) :3359 -70.
  • 8Hoffmann A, Ebert T, Kli~ting N,et al. Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin [ J ]. Biochim Biophys Acta, 2016, 1862(1) :113 -20.
  • 9Miyoshi T, Onoue G, Hirohata A, et al. Serum adipocyte fatty acid-binding protein is independently associated with coronary ath- emsclerotie burden measured by irttravascular ultrasound[J].Ath- erosclerosis,2010,211 ( 1 ) : 164 - 9.
  • 10Bhatt P M, Malgor R. Wnt5 a: a player in the pathogenesis of ath- erosclerosis and other inflammatory disorders[J].Atherosclerosis, 2014,237( 1 ) :155 -62.

共引文献5177

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部